Welcome : Guest

DURECT Corporation (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about DURECT Corporation, which is principally involved in Biopharmaceuticals Business. Illustrated with 44 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-09259
Price: $2200
Company Type: Public
Pages: 48
Date: November 2016
Market Data Tables: 44

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: DURECT Corporation’s Sales by Product Category Worldwide (2014-2015) in Percentage for Collaborative Research and Development and Others, and Pharmaceutical Products......3
Table 2: DURECT Corporation’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for United States, Japan, Europe, and Others......4
Chronic Pain......7
Table 3: Chronic Pain in Adults by Pain Type in the US (2015) - Percentage Share Breakdown by Volume for Knee Pain, Low Back Pain, Serve Headache or Migraine......7
Table 4: Spinal Cord Stimulation (SCS) Population by Category in the US (2015) - Percentage Share Breakdown by Volume for Failed Back Surgery Syndrome, Oral Opioids, and Others......8
Table 5: Spinal Cord Stimulation Systems for Chronic Pain (incl. back pain, leg pain and back/leg pain) Market Worldwide (2015) in US$ Million......9
Table 6: No. of People with Chronic Pain in the US (2015-2020) in Million......10
Table 7: Spinal Cord Stimulation (SCS) for Chronic Pain by Category in the US (2015) - Percentage Share Breakdown by Volume for Back Pain alone, Leg & Back Pain, Leg Pain alone and Upper Extremity Pain......11
Table 8: No. of Population with Chronic Pain by Age in the US (2015) - Percentage Share Breakdown by Volume for 18 & over and 18 & Under......12
Table 9: No. of Population with Chronic Pain by Type in the US (2015) - Percentage Breakdown by Volume for Back Pain and Other Pain......13
Pain Drugs......14
Table 10: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......14
Extended-Release Opioid......15
Table 11: Extended-Release Opioid Market by Payment Method in the US (2015) - Percentage Share Breakdown by Value for Cash, Commercial, Managed Medicaid, Medicaid and Medicare......15
Antipsychotic Drugs......16
Table 12: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......16
Table 13: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......17
Table 14: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......18
Lipid-Lowering Drugs......19
Table 15: Lipid-Lowering Drug Market by Product Category China (2015) - Percentage Share Breakdown by Value for Statins, Xuezhikang, and Other Products......19
Ophthalmology......20
Table 16: Ophthalmology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Ophthalmic pharmaceuticals, Surgical, and Vision Care......20
Table 17: Ophthalmology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cataract & Vitreoretinal Surgery, Ophthalmic Lasers, and Vision Care......21
Table 18: Ophthalmology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 45-64 Years, 65+ Years Age, and Others......22
Ophthalmic Drugs......23
Table 19: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......23
Table 20: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......24
Glaucoma......25
Table 21: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......25
Table 22: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......26
Glaucoma Drugs......27
Table 23: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......27
Table 24: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......28
Pain Management Drugs......29
Table 25: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......29
Table 26: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......30
Table 27: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......31
Table 28: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......32
Table 29: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Others......33
Table 30: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......34
Narcotic Drugs......35
Table 31: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......35
Table 32: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......36
Opioids......37
Table 33: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others......37
Non-Narcotic Patch......38
Table 34: Non-Narcotic Patch Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Flector, Lidoderm, MNK-395, Pennsaid, and Voltaren Gel......38
Attention Deficit Hyperactivity Disorder (ADHD)......39
Table 35: Market Shares of Leading Drugs for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the US (2015) - Percentage Share Breakdown by Value for Intuniv, Strattera and Others......39
Antipsychotic Drugs......40
Table 36: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......40
Table 37: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......41
Table 38: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......42
Table 39: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......43
Methylphenidate......44
Table 40: Methylphenidate Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Concerta, Dexmethylphenidate Extended-Release, Focalin XR, Methylphenidate Extended-Release (ER), Methylphenidate Immediate-Releade (IR) and Others......44
Ophthalmology Drugs......45
Table 41: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......45
Table 42: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......46
Table 43: DURECT Corporation’s Sales by Geographic Region Worldwide (2013) in Percentage for United States, Europe, Japan and Others......47
Table 44: DURECT Corporation’s Revenues by Category Worldwide (2011-2013) in US$ Thousands for Collaborative Research and Development and Other Revenue and Product Revenue......48